These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 20028562)
1. Gain in cellular organization of inflammatory breast cancer: A 3D in vitro model that mimics the in vivo metastasis. Morales J; Alpaugh ML BMC Cancer; 2009 Dec; 9():462. PubMed ID: 20028562 [TBL] [Abstract][Full Text] [Related]
2. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Tomlinson JS; Alpaugh ML; Barsky SH Cancer Res; 2001 Jul; 61(13):5231-41. PubMed ID: 11431364 [TBL] [Abstract][Full Text] [Related]
3. Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma. Alpaugh ML; Tomlinson JS; Ye Y; Barsky SH Am J Pathol; 2002 Aug; 161(2):619-28. PubMed ID: 12163386 [TBL] [Abstract][Full Text] [Related]
4. Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma. Alpaugh ML; Tomlinson JS; Kasraeian S; Barsky SH Oncogene; 2002 May; 21(22):3631-43. PubMed ID: 12032865 [TBL] [Abstract][Full Text] [Related]
5. The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin. Ye Y; Tian H; Lange AR; Yearsley K; Robertson FM; Barsky SH Oncogene; 2013 Mar; 32(13):1702-13. PubMed ID: 22580607 [TBL] [Abstract][Full Text] [Related]
6. Geometric tumor embolic budding characterizes inflammatory breast cancer. Modi AP; Nguyen JPT; Wang J; Ahn JS; Libling WA; Klein JM; Mazumder P; Barsky SH Breast Cancer Res Treat; 2023 Feb; 197(3):461-478. PubMed ID: 36473978 [TBL] [Abstract][Full Text] [Related]
7. The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Xiao Y; Ye Y; Yearsley K; Jones S; Barsky SH Am J Pathol; 2008 Aug; 173(2):561-74. PubMed ID: 18599608 [TBL] [Abstract][Full Text] [Related]
8. E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking. Ye Y; Tellez JD; Durazo M; Belcher M; Yearsley K; Barsky SH Anticancer Res; 2010 Oct; 30(10):3903-10. PubMed ID: 21036701 [TBL] [Abstract][Full Text] [Related]
9. Early to intermediate steps of tumor embolic formation involve specific proteolytic processing of E-cadherin regulated by Rab7. Ye Y; Gao JX; Tian H; Yearsley K; Lange AR; Robertson FM; Barsky SH Mol Cancer Res; 2012 Jun; 10(6):713-26. PubMed ID: 22638108 [TBL] [Abstract][Full Text] [Related]
10. Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion. Mahooti S; Porter K; Alpaugh ML; Ye Y; Xiao Y; Jones S; Tellez JD; Barsky SH Oncotarget; 2010 Jun; 1(2):131-147. PubMed ID: 21297224 [TBL] [Abstract][Full Text] [Related]
11. Persistent E-cadherin expression in inflammatory breast cancer. Kleer CG; van Golen KL; Braun T; Merajver SD Mod Pathol; 2001 May; 14(5):458-64. PubMed ID: 11353057 [TBL] [Abstract][Full Text] [Related]
12. Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo. Alpaugh ML; Barsky SH Hum Gene Ther; 2002 Jul; 13(10):1245-58. PubMed ID: 12133277 [TBL] [Abstract][Full Text] [Related]
13. Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroids. Robertson FM; Woodward WA; Pickei R; Ye Z; Bornmann W; Pal A; Peng Z; Hall CS; Cristofanilli M Cancer; 2010 Jun; 116(11 Suppl):2760-7. PubMed ID: 20503408 [TBL] [Abstract][Full Text] [Related]
14. PLEKHA7, an Apical Adherens Junction Protein, Suppresses Inflammatory Breast Cancer in the Context of High E-Cadherin and p120-Catenin Expression. Pence LJ; Kourtidis A; Feathers RW; Haddad MT; Sotiriou S; Decker PA; Nassar A; Ocal IT; Shah SS; Anastasiadis PZ Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525380 [TBL] [Abstract][Full Text] [Related]
15. Initiation of tumor dormancy by the lymphovascular embolus. Ye Y; Wang J; Izban MG; Ballard BR; Barsky SH Oncotarget; 2024 Oct; 15():726-740. PubMed ID: 39392391 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. Klopp AH; Lacerda L; Gupta A; Debeb BG; Solley T; Li L; Spaeth E; Xu W; Zhang X; Lewis MT; Reuben JM; Krishnamurthy S; Ferrari M; Gaspar R; Buchholz TA; Cristofanilli M; Marini F; Andreeff M; Woodward WA PLoS One; 2010 Aug; 5(8):e12180. PubMed ID: 20808935 [TBL] [Abstract][Full Text] [Related]
17. Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant. dit Faute MA; Laurent L; Ploton D; Poupon MF; Jardillier JC; Bobichon H Clin Exp Metastasis; 2002; 19(2):161-8. PubMed ID: 11964080 [TBL] [Abstract][Full Text] [Related]
18. CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer. Kai K; Iwamoto T; Zhang D; Shen L; Takahashi Y; Rao A; Thompson A; Sen S; Ueno NT Sci Rep; 2018 Jun; 8(1):9427. PubMed ID: 29930294 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory breast cancer (IBC): clues for targeted therapies. Fernandez SV; Robertson FM; Pei J; Aburto-Chumpitaz L; Mu Z; Chu K; Alpaugh RK; Huang Y; Cao Y; Ye Z; Cai KQ; Boley KM; Klein-Szanto AJ; Devarajan K; Addya S; Cristofanilli M Breast Cancer Res Treat; 2013 Jul; 140(1):23-33. PubMed ID: 23784380 [TBL] [Abstract][Full Text] [Related]
20. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin. Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]